Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00877136 · ClinicalTrials.gov registry record
A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
A clinical trial, sponsored by St. Joseph Hospital of Orange.
- Completed
- Registry status
- 18
- Enrollment target
NCT00877136 is a clinical trial that has completed, run by St. Joseph Hospital of Orange. The registered enrollment target is 18 participants.
The verdict
NCT00877136 has completed, sponsored by St. Joseph Hospital of Orange.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This is an interdisciplinary study that falls into the Humanitarian Use Device category. There are no hypotheses to be tested in this treatment protocol. The study has the following objectives: 1. Provide supervised access to treatment with TheraSphere® to eligible patients with primary cancer to the liver who are not surgical resection candidates. 2. Evaluate patient experience and toxicities associated with TheraSphere® treatment. 3. Measure tumor response rates
Interventions
- DEVICE TheraSphere®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2009-02 |
| Est. Completion | 2021-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00877136
The ClinicalTrials.gov registry entry for NCT00877136 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Joseph Hospital of Orange, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TheraSphere® is the first listed.
NCT00877136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00877136 about?
NCT00877136 is a clinical study titled "A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®". This is an interdisciplinary study that falls into the Humanitarian Use Device category. There are no hypotheses to be tested in this treatment protocol. The study has the following objectives: 1. Provide supervised access to treatment with TheraSphere® to eligible patients with primary cancer to t...
What is the current status of trial NCT00877136?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2009-02. Estimated completion is 2021-03.
What interventions are being tested in trial NCT00877136?
The interventions under investigation include: TheraSphere® (DEVICE).
Who is sponsoring clinical trial NCT00877136?
This trial is sponsored by St. Joseph Hospital of Orange, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.